# Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder

> **NCT02901249** · PHASE4 · COMPLETED · sponsor: **Federal University of Rio Grande do Sul** · enrollment: 68 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** sertraline
- **DRUG:** Nortriptyline
- **DRUG:** Lithium

## Key facts

- **NCT ID:** NCT02901249
- **Lead sponsor:** Federal University of Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2014-11
- **Final completion:** 2015-09
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901249, "Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02901249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*